N3-PEG8-Phe-Lys-PABC-Gefitinib

Product Description: N3-PEG8-Phe-Lys-PABC-Gefitinib is a agent-linker conjugate for ADC with potent antitumor activity by using the anti-tumor agent, Gefitinib (orally active EGFR tyrosine kinase inhibitor), linked via the cleavable linker N3-PEG8-Phe-Lys-PABC. N3-PEG8-Phe-Lys-PABC-Gefitinib is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.

Applications: Cancer-Kinase/protease

Formula: C60H81ClFN11O15

Molecular Weight: 1250.80

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: Drug-Linker Conjugates for ADC

• Artikelnummer: MEXHY-131088-0
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-131088-0
• Green Labware: Nein
• Verpackungseinheit: Get quote
• Mengeneinheit: STK